Related references
Note: Only part of the references are listed.Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
MARC DE HERT et al.
World Psychiatry (2015)
Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness
Sameed Ahmed M. Khatana et al.
PLOS ONE (2011)
Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance
Karen E. Moeller et al.
SCHIZOPHRENIA RESEARCH (2011)
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
Marc De Hert et al.
WORLD PSYCHIATRY (2011)
Prediabetes Assessment and Follow-up in Older Veterans With Schizophrenia
Laurel A. Copeland et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs
Elaine H. Morrato et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Promoting physical health in youth mental health services: ensuring routine monitoring of weight and metabolic indices in a first episode psychosis clinic
Sarah Hetrick et al.
AUSTRALASIAN PSYCHIATRY (2010)
Implementing a physical health strategy in a mental health service
Bridget Organ et al.
AUSTRALASIAN PSYCHIATRY (2010)
Implementing clinical guidelines in psychiatry: a qualitative study of perceived facilitators and barriers
Tord Forsner et al.
BMC PSYCHIATRY (2010)
Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis
Nicolas A. Crossley et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis
Oliver Lord et al.
GENERAL HOSPITAL PSYCHIATRY (2010)
The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness
R. I. G. Holt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis
Alex J. Mitchell et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Treatment Settings and Metabolic MONITORING for People Experiencing First-Episode Psychosis
Catherine Batscha et al.
JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES (2010)
Swedish clinical guidelines-Prevention and management of metabolic risk in patients with severe psychiatric disorders
Dan Gothefors et al.
NORDIC JOURNAL OF PSYCHIATRY (2010)
From PORT to Policy to Patient Outcomes: Crossing the Quality Chasm
Harold Alan Pincus
SCHIZOPHRENIA BULLETIN (2010)
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
Christine Rummel-Kluge et al.
SCHIZOPHRENIA RESEARCH (2010)
Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study
Lauren C. Bresee et al.
SCHIZOPHRENIA RESEARCH (2010)
Monitoring the metabolic side-effects of atypical antipsychotics
Rohit Gumber et al.
PSYCHIATRIC BULLETIN (2010)
Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents
Dan W. Haupt et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
An evaluation of monitoring practices in patients on second generation antipsychotics
Dang Nguyen et al.
AUSTRALASIAN PSYCHIATRY (2009)
Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration
Lizheng Shi et al.
BMC PSYCHIATRY (2009)
Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies
Alex J. Mitchell et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes
Elaine H. Morrato et al.
DIABETES CARE (2009)
Who should swing the stethoscope? An audit of baseline physical examination and blood monitoring on new patients accepted by an early intervention in psychosis team
Jim Crabb et al.
EARLY INTERVENTION IN PSYCHIATRY (2009)
Drawing up guidelines for the attendance of physical health of patients with severe mental illness
D. Saravane et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2009)
Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: A cross-sectional study in a low cardiovascular disease risk geographical area
M. Bernardo et al.
EUROPEAN PSYCHIATRY (2009)
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
M. De Hert et al.
EUROPEAN PSYCHIATRY (2009)
Metabolic Risk Status and Second-Generation Antipsychotic Drug Selection A Retrospective Study of Commercially Insured Patients
Elaine H. Morrato et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Do Antipsychotics Cost Lives or Save Lives? Risks Versus Benefits From Large Epidemiological Studies
Alex J. Mitchell
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Retrospective Analysis of Diabetes Care in California Medicaid Patients with Mental Illness
Jim E. Banta et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
The incidence of diabetes in atypical antipsychotic users differs according to agent-results from a multisite epidemiologic study
Marianne Ulcickas Yood et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Metabolic Risk Factors Among Medicaid Outpatients With Schizophrenia Receiving Second-Generation Antipsychotics
Ryan Bell et al.
PSYCHIATRIC SERVICES (2009)
Influence of antipsychotics on mortality in schizophrenia: Systematic review
Stefan Weinmann et al.
SCHIZOPHRENIA RESEARCH (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme
T. R. E. Barnes et al.
ACTA PSYCHIATRICA SCANDINAVICA (2008)
Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review
Anneke L. Francke et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2008)
First- V. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis
M. Smith et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Insulin sensitivity, adjusted β-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: A nine-month prospective study
P. Oriot et al.
DIABETES & METABOLISM (2008)
Epidemiological study for the evaluation of metabolic disorders in patients with schizophrenia: The METEOR Study
M. De Hert et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Awareness of metabolic concerns in patients with bipolar disorder: A survey of European psychiatrists
Michael Bauer et al.
EUROPEAN PSYCHIATRY (2008)
Gender differences in metabolic monitoring of second-generation antipsychotic prescription
Helene Verdoux et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: A retrospective, population-based study of medicaid claims data
Elaine H. Morrato et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Comorbid somatic illnesses in patients with severe mental disorders:: Clinical, policy, and research challenges
W. Wolfgang Fleischhacker et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
MEDICALLY CLEARED: HOW WELL ARE PATIENTS WITH PSYCHIATRIC PRESENTATIONS EXAMINED BY EMERGENCY PHYSICIANS?
Mikolaj Szpakowicz et al.
JOURNAL OF EMERGENCY MEDICINE (2008)
Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: Findings from a Veterans Affairs-based population
Chienning Hsu et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2008)
Brazilian Consensus on second-generation antipsychotics and metabolic disorders
Helio Elkis et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2008)
A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study
Celso Arango et al.
SCHIZOPHRENIA RESEARCH (2008)
Routine laboratory screening among newly admitted psychiatric patients: Is it worthwhile?
Rosario Arce-Cordon et al.
PSYCHIATRIC SERVICES (2007)
Dysglycemia in a community sample of people treated for schizophrenia: The diabetes in schizophrenia in central-south Ontario (DiSCO) study
L. P. Voruganti et al.
SCHIZOPHRENIA RESEARCH (2007)
Physical illness and schizophrenia: a review of the literature
S. Leucht et al.
ACTA PSYCHIATRICA SCANDINAVICA (2007)
A systematic review of mortality in schizophrenia - Is the differential mortality gap worsening over time?
Sukanta Saha et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder
Amy M. Kilbourne et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia
A. H. Barnett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: Missed targets and lost opportunities
Christoph U. Correll et al.
SCHIZOPHRENIA RESEARCH (2007)
Quality of diabetes care among adults with serious mental illness
Richard W. Goldberg et al.
PSYCHIATRIC SERVICES (2007)
Gaps between knowing and doing: Understanding and assessing the barriers to optimal health care
Lorna J. Cochrane et al.
JOURNAL OF CONTINUING EDUCATION IN THE HEALTH PROFESSIONS (2007)
The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management
K. Usher et al.
JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING (2006)
Lipid monitoring in patients with schizophrenia prescribed second-generation antipsychotics
Ellen M. Weissman et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline
Henry A. Nasrallah et al.
SCHIZOPHRENIA RESEARCH (2006)
Treatment of cardiac risk factors among patients with schizophrenia and diabetes
Anthony P. Weiss et al.
PSYCHIATRIC SERVICES (2006)
Blood glucose testing for adults prescribed atypical antipsychotics in primary and secondary care
Catharine Jane Tarrant
PSYCHIATRIC BULLETIN (2006)
Medical complications of anorexia nervosa and bulimia nervosa
James E. Mitchell et al.
CURRENT OPINION IN PSYCHIATRY (2006)
Diabetes treatment among VA patients with comorbid serious mental illness
Sarah L. Krein et al.
PSYCHIATRIC SERVICES (2006)
Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness
Julie Kreyenbuhl et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2006)
From silos to bridges: Meeting the general health care needs of adults with severe mental illnesses
Marcella Horvitz-Lennon et al.
HEALTH AFFAIRS (2006)
Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia Medicaid enrollees in 2001
Hua Chen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Disparities in diabetes care - Impact of mental illness
SM Frayne et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
JM Meyer et al.
SCHIZOPHRENIA RESEARCH (2005)
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III
JP McEvoy et al.
SCHIZOPHRENIA RESEARCH (2005)
Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
PF Buckley et al.
SCHIZOPHRENIA RESEARCH (2005)
Atypical antipsychotics in psychiatric practice: Practical implications for clinical monitoring
MJ Poulin et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2005)
Belgian consensus on metabolic problems associated with atypical antipsychotics
A De Nayer et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2005)
Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs
D Taylor et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York
JA Staller et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2005)
Consensus development conference on antipsychotic drugs and obesity and diabetes
DIABETES CARE (2004)
The effects of antipsychotic therapy on serum lipids: a comprehensive review
JM Meyer et al.
SCHIZOPHRENIA RESEARCH (2004)
Testing for diabetes in hospitalised patients prescribed antipsychotic drugs
D Taylor et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism
KI Melkersson et al.
PSYCHOPHARMACOLOGY (2004)
Physical health monitoring of patients with schizophrenia
SR Marder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses
LB Dixon et al.
PSYCHIATRIC SERVICES (2004)
Atypical antipsychotics and glucose dysregulation: a systematic review
H Jin et al.
SCHIZOPHRENIA RESEARCH (2004)
Receipt of diabetes services by insured adults with and without claims for mental disorders
LE Jones et al.
MEDICAL CARE (2004)
What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
TA Sheldon et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs
C Paton et al.
ACTA PSYCHIATRICA SCANDINAVICA (2004)
Mental disorders and quality of diabetes care in the veterans health administration
MM Desai et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Share Paper
